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Abstract
Background: Smartphone technology represents an opportunity to deliver practical 
solutions for people affected by cancer at a scale that was previously unimaginable, 
such as information, appointment monitoring, and improved access to cancer support 
services. This study aimed to determine whether a smartphone application (app) re-
duced the unmet needs among people newly diagnosed with cancer.
Methods: A single blind, multisite randomized controlled trial to determine the im-
pact of an app-based, 4-month intervention. Newly diagnosed cancer patients were 
approached at three health service treatment clinics.
Results: Eighty-two people were randomized (intervention; n  =  43 and control; 
n = 39), average age was 59.5 years (SD: 12.9); 71% female; 67% married or in a 
de facto relationship. At baseline, there were no differences in participants’ charac-
teristics between the groups. No significant effects, in reducing unmet needs, were 
demonstrated at the end of intervention (4-month) or 12-month follow-up. Overall, 
94% used the app in weeks 1-4, which decreased to 41% in weeks 13-16. Mean app 
use time per participant: Cancer Information, 6.9 (SD: 18.9) minutes; Appointment 
Schedule, 5.1 (SD: 9.6) minutes; Cancer Services 1.5 minutes (SD: 6.8); Hospital 
Navigation, 1.4 (SD: 2.8) minutes.
Conclusions: Despite consumer involvement in the design of this smartphone tech-
nology, the app did not reduce unmet needs. This may have been due to the study 
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1 |  INTRODUCTION
With improved diagnostic and treatment options, seven in 10 
people are surviving cancer beyond 5 years and over one mil-
lion people in Australia are currently survivors of cancer.1 
People diagnosed with cancer experience moderate levels 
of both distress and unmet needs during treatment and into 
the survivorship phase of their condition. It is well-estab-
lished that information provision and support is essential to 
high quality care and results in psychosocial benefits to peo-
ple diagnosed with cancer.2 While distress can be prevalent 
throughout the cancer trajectory, high levels are found par-
ticularly at diagnosis and during active cancer treatment.3-5 
Mehnert and colleagues, using the distress thermometer 
(DT), reported high levels of distress symptoms (DT >4) in 
52% of cancer patients with the prevalence increasing to 81% 
in the presence of sleep problems, fatigue, and difficulties 
getting around.4 Previous studies have also demonstrated 
that high levels of emotional distress are associated with de-
creased quality of life, high symptom burden, and poor adher-
ence to treatment.6,7
Despite consistent evidence and widespread acknowl-
edgment of the psychological impact of a cancer diagnosis, 
unmet needs which may contribute to an individual's distress 
are poorly recognized and undertreated.8 Unmet needs refer 
to the gap between a person's experience of services and the 
actual services required or desired.9 A systematic review 
found that up to 93% of newly diagnosed patients reported 
unmet needs across a range of domains comprising psycho-
logical, informational, and physical.10 An earlier review11 
identified that the most common unmet needs were those 
associated with activities of daily living, economic needs, 
physical needs, supportive care needs, and sexuality. This 
situation has not changed in nearly a decade with similar pat-
terns and predictors of unmet needs reported by Okediji and 
colleagues in 2017.12
With the rapid development of information science and 
technology, digital health has become an important tool for 
health care. As a result, many people seek health-related in-
formation on the Internet.13,14 However, concerns over the 
quality of information14 and level of e-health literacy15 high-
light the need to provide people affected by cancer with qual-
ity and flexible access to information from reputable sources.
Smartphone technology represents an opportunity to de-
liver practical solutions at a scale that was previously un-
imaginable. It offers new possibilities for health promotion 
and treatment management that can reach patients regardless 
of where they live, including appointment monitoring,16,17 
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improved access to cancer information and support ser-
vices,18 and lead to improve their participation in health care 
over time.19,20
To inform the development of the smartphone appli-
cation (app), we undertook focus groups to determine the 
type of features that would be important to include in an 
app. Based on consumer feedback, the smartphone app 
prototype, referred to as the ACE app, was developed with 
partners, Barwon Health, Simble Solutions© and Optus©. 
ACE was a free to user, downloadable application to a 
smartphone or similar tablet device designed for people 
affected by cancer. It provided access to a list of appoint-
ments from their treating health service; targeted infor-
mation on patient's cancer type; increased awareness and 
access to the Cancer Council Victoria's Cancer Information 
and Support Service (CISS) that linked people to a range 
of community-based supportive care services as required; 
and identification of distress. Those with elevated levels of 
distress were signaled by IT services and referred to CISS 
with a name and contact telephone number for referral to 
psychological services.
The ACE app was piloted with a convenience sample of 
20 people newly diagnosed with cancer. The app recorded 
250 hits in the first month alone, suggesting the app would be 
acceptable to, and useful for, this population group.
The current study aimed to assess through a randomized 
controlled trial whether access to the ACE app for a 4-month 
period reduced unmet needs during the treatment period. 
Secondary aims were to determine whether the app reduced 
distress and was used by participants. We tested the hypoth-
eses that access to the ACE app would reduce unmet needs 
(with particular reference to informational needs during treat-
ment) and levels of distress.
2 |  MATERIALS AND METHODS
2.1 | Research design
A single blinded, multisite randomized controlled trial to 
determine the efficacy of the ACE smartphone app inter-
vention delivered for 4 months among newly diagnosed can-
cer patients. Assessments occurred at baseline, and 4, and 
12 months following recruitment.
2.1.1 | Setting
The study was undertaken across one private and two 
public health services or hospitals in Victoria Australia. 
Participating health services were situated in urban and 
rural areas with socially diverse patient populations and 
similar IT operating systems. The health-care system in 
Australia comprises both government (public health ser-
vices) and private hospitals that are owned and managed 
privately but licensed and regulated by the Government. 
Recruitment occurred between February 2017 and January 
2018.
2.1.2 | Procedures
Newly diagnosed cancer patients were identified and 
screened for eligibility by medical or nurse clinicians at each 
of the three health services. Research trained personnel were 
provided with a list of eligible patients who were then ap-
proached in the outpatient oncology setting. Each patient was 
given a brief introduction to the study. Interested patients 
received a study pack (consent form and questionnaire) to 
take home and were then followed-up over the phone within 
48 hours by the research project manager to answer any ques-
tions and to confirm participation. Patients then completed 
and returned the written informed consent and baseline ques-
tionnaire using a reply-paid envelope. Following return of 
the consent form, participants were allocated to the study 
arm based on computer-generated randomization sequences, 
stratified by health service and patient's age, produced by the 
trial statistician.
For those allocated to the intervention, research person-
nel at each health service downloaded the app onto the par-
ticipant's smartphone or similar tablet device and showed 
features of the app at their next treatment appointment. 
Participants allocated to the control group received usual 
care, from their treating health service.
2.1.3 | Participant inclusion criteria
Adults, aged 18+ years, with a new cancer diagnosis; with 
curative intent (stages 1-3) and attending outpatient treat-
ment settings for cycle 2-5 of adjuvant chemotherapy or 
fraction 2-5 for radiotherapy treatment; able to complete 
English language questionnaires; and having access to a 
smartphone or similar tablet device. Exclusion criterion 
was cognitive dysfunction (psychotic illness or demen-
tia) as determined by experienced health service oncology 
nurses.
2.2 | Intervention
The smartphone app comprised the following features:
1. Login/ logout;
2. Cancer information, links to reputable cancer sites, for 
example, the National Cancer Institute, Cancer Institute 
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NSW (eviQ), Cancer Council Victoria (CCV) Treatment, 
Lifestyle and Emotion, and Cancer booklets;
3. Information on the CCV and support service;
4. Health Service Navigation, provision of maps to enable 
participants to navigate their way around their health ser-
vice, and information on transport, parking, facilities and 
services available;
5. Information on allied services at each health service, for 
example nutrition and dietetics, speech pathology, psy-
chology, social work, physiotherapy;
6. Appointment schedule. The ACE app was linked into the 
health service IT system, showing a list of upcoming treat-
ment appointments and facilitated requests to re-schedule 
existing bookings (triggered an automatic email to the 
clinic receptionist at the health service);
7. Distress Thermometer21 with a prompt to complete it at 
baseline and monthly thereafter for 4 months. The DT 
is a one-item screening tool for the detection of gener-
alized distress, with scores from 0 (no distress) to 10 
(extreme distress). Scores 4 to 6 prompted a notifica-
tion to the participant, recommending they contact CISS 
and phone number; scores of ≥7 triggered an automatic 
request to the participant whether they would like a can-
cer nurse to contact them from CISS. If the participant 
responded yes, an email (containing the participant's 
contact information and DT score) was sent to CISS 
for follow-up with the participant within 4 hours. If the 
participant declined the referral, emergency telephone 
numbers were provided.
8. Links to clinical trials information fact sheets from CCV 
and contact details of clinical trial coordinators at each 
health service;
9. A Notebook for writing down questions prior to consulta-
tions; and
10. Emergency telephone numbers if needed during out of 
business hours.
While the app comprised 10 features, only the Appointment 
schedule, DT, and Notebook required login so the nav-
igational format was flexible depending on the partici-
pant's needs to support sustained use over the intervention 
period.22
2.3 | Data collection
Questionnaires were distributed by mail with a reply-paid 
envelope to return to the project manager. Demographic 
and clinical characteristics were collected at baseline and 
included information on participant age, gender, postcode, 
education, cultural background, employment status, liv-
ing situation, marital status, cancer type, stage and current 
treatment.
2.4 | Outcome measures
2.4.1 | Primary outcome
Unmet needs were ascertained using the Supportive Care 
Needs Survey (SCNS-SF34) which measures the unmet 
needs of cancer patients across the illness trajectory. This 
questionnaire comprises the following five domains: health 
system and information needs; physical and daily living 
needs; psychological needs; sexuality needs; and patient 
care and support needs. The scale has been validated with 
cancer patients, is reliable, and has demonstrated good con-
tent and construct validity for measuring global needs in 
cancer patients.23,24
2.4.2 | Secondary outcomes
Impact of Events Scale (IES-R). The IES-R is an index of 
cancer-specific distress. This 22-item scale evaluates stress 
reactions after traumatic experiences such as having been di-
agnosed with cancer. Responses are made on a 5-point Likert 
scale ranging from 0 (“not at all”) to 4 (“extremely”). Higher 
score indicates greater stress. The IES-R comprises three 
subscales, namely intrusion, avoidance, and hyper-arousal. 
The IES-R has been used frequently to assess the distress fol-
lowing a cancer diagnosis and has been found to have good 
internal consistency.25
Health Education Impact Questionnaire was designed to 
evaluate the intended benefits of a wide variety of self-man-
agement programs. It is used in over 20 countries and has 
been adapted to the cancer setting.26 It contains 40 questions 
across eight scales, each with high reliability. Two highly 
reliable scales, Health Service Navigation, which measures 
the confidence and ability to communicate and negotiate 
with health service providers, and Emotional Distress, which 
measures negative affective responses reflected the intended 
outcomes of the intervention.
Health Literacy Questionnaire measures a person's capac-
ity to seek, understand, and use health information. The tool 
provides insight into client-practitioner interactions, guides 
program redevelopment and organizational responses to pop-
ulations with low health literacy, specifically “having suffi-
cient information to manage my health”; “actively managing 
my health”; “ability to actively engage with health-care pro-
viders”; “navigating the health-care system”; and the “ability 
to find good health information.”27
Satisfaction with the ACE app. Information on the use-
fulness and acceptability of the app was obtained from par-
ticipants in the intervention arm at the first follow-up. The 
questionnaire included questions about participants’ expec-
tations of the app and what features of the app were or were 
not taken up.
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App usage was extracted from data downloaded from a 
cloud-based server, hosted by the developers of the app.
2.5 | Sample size calculations
The main outcome was a reduction in unmet needs as meas-
ured by each of the five domains of the SCNS-SF34. We 
planned to use linear mixed models with three measurement 
points (baseline, 4, and 12 months), and the F-test to assess 
the study arm by time interaction (α  =  .05). Assuming a 
standard deviation of 30 and an intraclass correlation coef-
ficient of 0.2 (or as high as 0.8), a study with 125 patients 
evaluated three times in each arm had 80% power to detect 
a reduction of 14.5 (or 7.25) at 4 months and maintained (if 
not increased) at 12 months. Reductions in this range were 
comparable to the significant differences (7.7-15.0), reported 
by Boyes et al,24 between cancer patients in, and not in, re-
mission, for 5 domains of the SCNS-SF34.
2.6 | Statistical analysis
Baseline characteristics of participants allocated to the two 
conditions were compared using the Chi-square or Fisher's 
exact test for categorical variables and t test for numerical 
variables. All analyses were based on an intention-to-treat 
(ITT) approach. The effect of the intervention on each of 
the outcomes was estimated using generalized estimating 
equations (GEE) with an exchangeable working correla-
tion matrix to account for the repeated measures. Models 
included group (intervention/control), time (baseline, 4, 
and 12 months), and the interaction study arm × time. No 
adjustment to the significance level for multiplicity of end-
points was performed. Effect of the intervention on number 
of moderate to high needs (score of 4 to 5) was also as-
sessed. All analyses were performed with SAS software, 
version 9.4 (SAS Institute).
3 |  RESULTS
A total of 270 people were screened for eligibility, of which 
76 (28%) were deemed ineligible. Overall, 112 (41%) peo-
ple declined to participate, the reasons are provided in 
Figure 1. A total of 82 people agreed to take part, the aver-
age age was 59.5 years (SD: 12.9); 71% were female; the 
majority were married or living in a de facto relationship 
(67%); 34% had a tertiary qualification; over half of the 
sample had breast cancer. Participants were randomized 
into intervention (n  =  43) and control (n  =  39) groups. 
Participants’ demographic characteristics are provided in 
Table 1. At baseline, there were no significant differences 
in participants’ demographic or clinical characteristics be-
tween the two groups. The overall attrition rate was 24% 
(intervention, 30%; control, 18%).
Table S2 presents the estimated mean for SCNS-SF34, 
unmet needs and IES-R outcomes for each measurement 
time and the differences in change from baseline between 
intervention and control groups. There were no significant 
differences between the groups in any of the outcomes. A 
downward trend for “physical and daily living needs” and 
“psychological needs” was observed from the SCNS-SF34 
over time and a downward trend to lower total distress scores 
in the intervention group at the 4 and 12 months follow-up 
was observed from the IES-R. Table S2 displays the same 
estimates for the other secondary outcomes.
3.1 | ACE app usage
Of the 43 participants randomized to the intervention group, 
the app could not be downloaded onto their devices for six 
participants due to technical issues. Findings from data 
analytics showed that over the 4-month trial period, 34 (of 
43 randomized to the ACE-app arm) participants accessed 
the ACE app (Table S3); 32 (94%) used the app in the first 
4 weeks of the intervention which decreased to 20 (59%) in 
weeks 5-8 and 9-12, with 14 (41%) in the final 13-16 weeks. 
Twenty (59%) participants logged in more than five times 
over the 16-week period, and 17% logged in three to four 
times. The most common features accessed were: Cancer 
Information (230 minutes; mean use per participant: 6.9 (SD 
18.9) minutes), Appointments (173.9 minutes; mean use per 
participant: 5.1 (SD 9.6) minutes), CISS services (49.9 min-
utes; mean use per participant 1.5 (SD: 6.8) minutes), and 
Hospital navigation (48.3 minutes; mean use per participant 
1.4 (SD: 2.8) minutes).
A total of 79 DT scores were recorded. Medium to high 
distress levels were recorded by 44% participants at base-
line, 44% of participants at the second monthly assessment, 
46% at the third monthly assessment, and 40% at the final 
assessment.
3.2 | ACE app feedback
Nearly two-thirds of participants (63%) reported that they 
strongly agreed or agreed that people would learn to use the 
app very quickly; 74% of participants reported they found the 
DT easy to complete on the app; 61% reported feeling con-
fident or very confident using the app, with only one person 
reporting not being confident using the app.
Representative feedback from participants included com-
ments that the app was “a good idea though as I found it 
confronting how much paper material/info I was bombarded 
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with”; “was easy to navigate to information and applicable 
material of interest (when connectivity issues actually en-
abled access)”; “I found appointments and some available 
services useful”; “while suffering from side effects of chemo 
then [the] app didn't help. At pain-free times information was 
useful”; “The developers are on a great path—keep going and 
well done and thank you.”
4 |  DISCUSSION
There has been increasing interest in mobile phones as a 
platform for interventions for people with cancer.28 A re-
cent systematic review highlighted mobile interventions 
for people with cancer only met treatment or symptom-
related information needs and did not meet patients' full 
range of cancer-related information needs, from informa-
tion on psychological support to how to manage finances 
during cancer, and the long-term effects of treatment.28 
Our smartphone app intervention attempted to fill this gap 
by providing information, support services, clinical trials 
information, and allied health resources to people newly 
diagnosed with cancer.
This smartphone app was designed to facilitate oppor-
tunities for improving person-centered care using mobile 
technology. While the ACE app was well-received and uti-
lized by participants, our study did not find it effective in 
reducing unmet needs among newly diagnosed cancer pa-
tients. It may be that current measures of unmet need are not 
sufficiently sensitive to consistently identify small changes 
that reflect the particular needs of an individual.29 However 
despite the lack of significant difference, the pattern of re-
sults for distress was encouraging with lower overall IES 
score for the intervention group compared to the control 
condition at both follow-up measures. The smaller than 
expected number of recruited participants, 82 instead of 
the projected 250 participants are likely to have limited the 
power of the study. The low recruitment was due to several 
issues relating to hospital IT systems which influenced the 
start date and participation of health services. At one health 
service, negotiations regarding IT firewalls introduced sub-
stantial delays in the project start date by 9 months, while 
F I G U R E  1  Consort diagram showing 
recruitment of participants into the study
Assessed for eligibility (n = 270)
Did not meet inclusion criteria (n = 76)
Patient does not speak English (n = 7)
Patient cognitively impaired (n = 2)
No Smartphone/tablet, no internet 
(n = 67)
Declined to participate (n = 112)
No time/too busy (n = 11)
Not interested (n = 21)
No need for support (n = 5)
Patient too unwell (n = 24)
Too burdensome, overwhelmed (n = 10)
Not confident in using apps, would not 
use app (n = 23)
No reason given (n = 10)                             
Unable to establish 48hr follow up call 
(n = 8)
Randomized (n = 82)
Allocated to intervention (n = 43)
Received intervention (n = 37)
Did not received the intervention (n = 6, app could not 
be installed in participant’s device)




Did not complete questionnaire (n = 1)
Included in analysis (n = 42)
Follow up 1
Withdrew from study (n = 3)
Did not complete questionnaire (n = 10)
Included in analysis (n = 30)
Follow up 2 
Withdrew from study (n = 2)
Patient passed away (n = 2)
Did not complete questionnaire (n = 7)
Included in analysis (n = 29)
Control
Baseline
Did not complete questionnaire (n = 0)
Included in analysis (n = 39)
Follow up 1
Withdrew from study (n = 1)
Did not complete questionnaire (n = 6)
Included in analysis (n = 32)
Follow up 2 
Withdrew from study (n = 0)
Patient passed away (n = 0)
Did not complete questionnaire (n = 7)
Included in analysis (n = 31)
Follow-up
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relocation of another large cancer-focused health service 
resulted in ongoing IT issues at this site; it became appar-
ent that recruitment of the planned number of patients for 
that particular site (n = 80) could not be achieved within 
the project time line.
Participants reported that the ACE app was acceptable in 
terms of ease of learning and DT completion. On average, 
participants recorded 2.3 of the recommended 4 DT scores, 
and for those who scored high distress levels and agreed to be 
referred were contacted by CISS for follow-up support. This 
Characteristics All Control (n = 39)
Intervention 
(n = 43) P-value
Age, mean (SD), y 59.5 (12.9) 58.8(13.7) 60.1 (12.4) .64a
Age groups, n (%), (y)
18-49 20 (24) 10 (26) 10 (23) .97b
50-59 15 (18) 7 (18) 8 (19)  
60 47 (57) 22 (56) 25 (58)  
Gender, n (%)
Male 24 (29) 13 (33) 11 (26) .44b
Female 58 (71) 26 (67) 32 (74)  
Marital status, n (%)
Single 8 (10) 4 (10) 4 (9) .22c
Married 49 (60) 21 (54) 28 (65)  
De facto 6 (7) 3 (8) 3 (7)  
Separated 2 (2) 1 (3) 1 (2)  
Divorced 9 (11) 3 (8) 6 (14)  
Widowed 8 (10) 7 (18) 1 (2)  
Education, n (%)
Secondary school 22 (27) 11 (28) 11 (26) .54c
Certificate or diploma 25 (31) 10 (26) 15 (35)  
University degree 28 (34) 13 (33) 15 (35)  
Other 7 (9) 5 (13) 2 (5)  
Employment, n (%)
Working full time 20 (26) 10 (26) 10 (25) .59
Working part time 15 (19) 8 (21) 7 (17)  
Retired 30 (39) 12 (32) 18 (45)  
Other 12 (16) 8 (21) 5 (13)  
Living situation, n (%)
Living by myself 17 (21) 10 (26) 7 (16) .39c
Living with partner/
spouse and/or family
60 (73) 27 (69) 33 (77)  
Living with friends 4 (5) 1 (3) 3 (7)  
Other 1 (1) 1 (3)    
Type of cancer, n (%)
Breast 50 (61) 21 (54) 29 (67) .69c
Prostate 2 (2) 1 (3) 1 (2)  
Colorectal 8 (10) 4 (10) 4 (9)  
Lung 4 (5) 3 (8) 1 (2)  
Others 22 (27) 13 (33) 9 (21)  
at test. 
bChi-squared test. 
cFisher's exact test. 
T A B L E  1  Demographic and clinical 
characteristics of participants in the ACE 
trial at baseline by condition (N = 82)
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app has the potential to reduce the burden of screening and 
follow-up in busy clinics for those flagged who were highly 
distressed, leaving clinicians free to focus on those who need 
specialized follow-up.
The results also showed that while usage was high-
est during the first month of the intervention, usage de-
creased thereafter. The most accessed features were Cancer 
Information, Appointments, CCV services, and Health ser-
vice navigation. A recent survey of hematology-oncology 
patients also reported interest in having access to health- 
related information via mobile apps with appointment man-
agement, advice on disease management, and communication 
with health professionals.30 The ACE app contained several 
of these features; however, it did not have an interactive 
component with health-care providers which may have had 
a more positive impact on patient outcomes, had symptom 
management or concerns as part of managing their disease 
been available.30 Moreover, engagement with self-guided in-
terventions can be low.31
4.1 | Study limitations
The current study was a randomized controlled study which 
provided precise measures of efficacy under ideal research 
conditions, resulting in results being less prone to bias.32 
The design also involved consumers from the early design 
stages with regular input and feedback. While collecting data 
on usage was a strength of our study, a limitation was that 
we could only capture data usage when the participant was 
logged into the app. As features such as information, CISS 
services, health service navigation, and clinical trials in-
formation could be accessed without logging onto the app, 
our count of access to these services may be an under-esti-
mate. We did not anticipate Internet variability across hos-
pital sites, with black spots located across different clinics, 
which resulted in downloading issues for some participants. 
Moreover, financial funding constraints did not allow for an 
extension of the recruitment period post the original recruit-
ment timeline of 12 months.
Our recruitment rate of 42% was consistent with previ-
ous research where recruitment among this population can 
vary from 20% to 60% for technology-based intervention 
studies.33 Sixty-seven (25%) patients approached did not 
have a smart phone or similar tool, which was low com-
pared to estimates of over 50% of people over the age of 
65 years using smartphones or tablets.34 Despite our study 
including a staff member demonstrating how to use the 
ACE app, a fifth of eligible patients declined participation 
because they did not feel confident in using apps or did not 
think they would use an app. This suggests that while smart 
phones might be widespread, their functionality may not 
be fully utilized by users including older users. In addition, 
nearly two-thirds of our sample had a breast cancer diag-
nosis. As this patient population may be better serviced 
compared to other cancer groups, further work is required 
to test the usefulness of health apps in studies that ensure 
inclusion of a broad representation of people affected by 
cancer.35
4.2 | Clinical implications
The practical difficulties in undertaking smartphone tech-
nology research are highlighted by this study. The prac-
ticality of apps may not match the reality in that people 
may use such apps initially but tend not to continue to use 
them consistently for longer periods. Providing additional 
information such as survivorship features or sharing the 
app with carers may facilitate ongoing use. Undertaking 
technology-based research in hospital settings can be prob-
lematic with Internet black spots, firewalls and technol-
ogy incompatibility, posing substantial impediments to the 
conduct of studies.36
4.3 | Conclusion
Expanding evaluation methodologies, that ensure robust 
study designs while allowing practical issues to be consid-
ered will contribute to a meaningful understanding and im-
proved implementation of smartphone applications.37
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